Advertisement
Advertisement

MREO

MREO logo

Mereo BioPharma Group plc - ADR

0.45
USD
Sponsored
+0.01
+1.36%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

0.45

+0.01
+1.12%

MREO Earnings Reports

Positive Surprise Ratio

MREO beat 1 of 6 last estimates.

17%

Next Report

Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.01
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
-75.00%

Mereo BioPharma Group plc - ADR earnings per share and revenue

On Nov 10, 2025, MREO reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.02 USD, resulting in a 59.68% surprise. Revenue reached --, compared to an expected 11.90 million, with a -100.00% difference. The market reacted with a +5.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.01 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Mereo BioPharma Group plc - ADR reported EPS of -$0.01, beating estimates by 59.68%, and revenue of $0.00, -100% below expectations.
The stock price moved up 5.65%, changed from $1.77 before the earnings release to $1.87 the day after.
The next earning report is scheduled for Mar 23, 2026.
Based on 10 analysts, Mereo BioPharma Group plc - ADR is expected to report EPS of -$0.01 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement